| Literature DB >> 27552145 |
Keefe T Chan1, Lassi Paavolainen2, Katherine M Hannan3,4, Amee J George3,5, Ross D Hannan1,3,4,5,6,7, Kaylene J Simpson6,8, Peter Horvath2,9, Richard B Pearson1,4,6,7.
Abstract
Hyperactivation of the PI3K/AKT/mTORC1 signaling pathway is a hallmark of the majority of sporadic human cancers. Paradoxically, chronic activation of this pathway in nontransformed cells promotes senescence, which acts as a significant barrier to malignant progression. Understanding how this oncogene-induced senescence is maintained in nontransformed cells and conversely how it is subverted in cancer cells will provide insight into cancer development and potentially identify novel therapeutic targets. High-throughput screening provides a powerful platform for target discovery. Here, we describe an approach to use RNAi transfection of a pre-established AKT-induced senescent cell population and subsequent high-content imaging to screen for senescence regulators. We have incorporated multiparametric readouts, including cell number, proliferation, and senescence-associated beta-galactosidase (SA-βGal) staining. Using machine learning and automated image analysis, we also describe methods to classify distinct phenotypes of cells with SA-βGal staining. These methods can be readily adaptable to high-throughput functional screens interrogating the mechanisms that maintain and prevent senescence in various contexts.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27552145 DOI: 10.1089/adt.2016.739
Source DB: PubMed Journal: Assay Drug Dev Technol ISSN: 1540-658X Impact factor: 1.738